+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Trimethyl chitosan-capped silver nanoparticles with positive surface charge: Their catalytic activity and antibacterial spectrum including multidrug-resistant strains of Acinetobacter baumannii



Trimethyl chitosan-capped silver nanoparticles with positive surface charge: Their catalytic activity and antibacterial spectrum including multidrug-resistant strains of Acinetobacter baumannii



Colloids and Surfaces. B Biointerfaces 155: 61-70



We report a facile route for the green synthesis of trimethyl chitosan nitrate-capped silver nanoparticles (TMCN-AgNPs) with positive surface charge. In this synthesis, silver nitrate, glucose, and trimethyl chitosan nitrate (TMCN) were used as silver precursor, reducing agent, and stabilizer, respectively. The reaction was carried out in a stirred basic aqueous medium at room temperature without the use of energy-consuming or expensive equipment. We investigated the effects of the concentrations of NaOH, glucose, and TMCN on the particle size, zeta potential, and formation yield. The AgNPs were characterized by UV-vis spectroscopy, photon correlation spectroscopy, laser Doppler anemometry, transmission electron microscopy, X-ray diffraction, and X-ray photoelectron spectroscopy. The catalytic activity of the TMCN-AgNPs was studied by the reduction of 4-nitrophenol using NaBH4 as a reducing agent. We evaluated the antibacterial effects of the TMCN-AgNPs on Acinetobacter baumannii, Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus using the broth microdilution method. The results showed that both gram-positive and gram-negative bacteria were killed by the TMCN-AgNPs at very low concentration (<6.13μg/mL). Moreover, the TMCN-AgNPs also showed high antibacterial activity against clinically isolated multidrug-resistant A. baumannii strains, and the minimum inhibitory concentration (MIC) was ≤12.25μg/mL.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 060427169

Download citation: RISBibTeXText

PMID: 28411476

DOI: 10.1016/j.colsurfb.2017.03.054


Related references

Silver Nanocomposite Biosynthesis: Antibacterial Activity against Multidrug-Resistant Strains of Pseudomonas aeruginosa and Acinetobacter baumannii. Molecules 21(9):, 2016

Silver nanoparticles synthesized with Eucalyptus critriodora ethanol leaf extract stimulate antibacterial activity against clinically multidrug-resistant Acinetobacter baumannii isolated from pneumonia patients. Microbial Pathogenesis 126: 245-257, 2019

Antibacterial Activity of Glutathione-Stabilized Silver Nanoparticles Against Campylobacter Multidrug-Resistant Strains. Frontiers in Microbiology 9: 458, 2018

In vitro Activity of Different Antibacterial Agents in Combination with Each Other against Multidrug-resistant Acinetobacter baumannii. Chinese Medical Journal 129(19): 2388-2389, 2016

Antibacterial Activity of In Situ Prepared Chitosan/Silver Nanoparticles Solution Against Methicillin-Resistant Strains of Staphylococcus aureus. Nanoscale Research Letters 13(1): 71, 2018

Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii. Journal of the Medical Association of Thailand 93(2): 161-171, 2010

Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York City. Antimicrobial Agents and ChemoTherapy 59(3): 1802-1805, 2015

In vitro activity of antimicrobial combination against multidrug-resistant strains of Acinetobacter baumannii. Korean Journal of Laboratory Medicine 25(5): 312-316, 2005

Treatment strategy by lactoperoxidase and lactoferrin combination: Immunomodulatory and antibacterial activity against multidrug-resistant Acinetobacter baumannii. Microbial Pathogenesis 114: 147-152, 2018

Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem. Antimicrobial Agents and ChemoTherapy 48(11): 4479-4481, 2004

In-vitro activity of the combination of colistin and rifampicin against multidrug-resistant strains of Acinetobacter baumannii. Journal Of Antimicrobial Chemotherapy. 41(4): 494-495, Il, 1998

In vitro reduction of antibacterial activity of tigecycline against multidrug-resistant Acinetobacter baumannii with host stress hormone norepinephrine. International Journal of Antimicrobial Agents 48(6): 680-689, 2016

The small molecule IITR08027 restores the antibacterial activity of fluoroquinolones against multidrug-resistant Acinetobacter baumannii by efflux inhibition. International Journal of Antimicrobial Agents 50(2): 219-226, 2017

Antibacterial effect of antibacterial fabrics against multidrug-resistant Acinetobacter baumannii complex. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 86(1): 31-33, 2012

In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii. Journal of Antimicrobial ChemoTherapy 66(5): 1047-1051, 2011